DNA methylation and the opposing NMDAR dysfunction in schizophrenia and major depression disorders: a converging model for the therapeutic effects of psychedelic compounds in the treatment of psychiatric illness
Authors:
- 7 September 2023
- journal article
- review article
- Published by Springer Nature in Molecular Psychiatry
- Vol. 28 (11) , 4553-4567
Abstract
Psychedelic compounds are being increasingly explored as a potential therapeutic option for treating several psychiatric conditions, despite relatively little being known about their mechanism of action. One such possible mechanism, DNA methylation, is a process of epigenetic regulation that changes gene expression via chemical modification of nitrogenous bases. DNA methylation has been implicated in the pathophysiology of several psychiatric conditions, including schizophrenia (SZ) and major depressive disorder (MDD). In this review, we propose alterations to DNA methylation as a converging model for the therapeutic effects of psychedelic compounds, highlighting the N-methyl D-aspartate receptor (NMDAR), a crucial mediator of synaptic plasticity with known dysfunction in both diseases, as an example and anchoring point. We review the established evidence relating aberrant DNA methylation to NMDAR dysfunction in SZ and MDD and provide a model asserting that psychedelic substances may act through an epigenetic mechanism to provide therapeutic effects in the context of these disorders.Keywords
Funding Information
- U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R21MH121836, R21MH129989, R01MH131053)
- U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
- U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
This publication has 210 references indexed in Scilit:
- New advances in NMDA receptor pharmacologyTrends in Pharmacological Sciences, 2011
- Distinct Modes of AMPA Receptor Suppression at Developing Synapses by GluN2A and GluN2B: Single-Cell NMDA Receptor Subunit Deletion In VivoNeuron, 2011
- Regulation of histone acetylation in the hippocampus of chronically stressed rats: a potential role of sirtuinsNeuroscience, 2011
- An upregulation of DNA-methyltransferase 1 and 3a expressed in telencephalic GABAergic neurons of schizophrenia patients is also detected in peripheral blood lymphocytesSchizophrenia Research, 2009
- Reduced levels of NR2A and NR2B subunits of NMDA receptor and PSD-95 in the prefrontal cortex in major depressionProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2009
- Elevated levels of NR2A and PSD-95 in the lateral amygdala in depressionInternational Journal of Neuropsychopharmacology, 2008
- Lineage-Specific Polycomb Targets and De Novo DNA Methylation Define Restriction and Potential of Neuronal ProgenitorsMolecular Cell, 2008
- Epigenetic mechanisms expressed in basal ganglia GABAergic neurons differentiate schizophrenia from bipolar disorderSchizophrenia Research, 2007
- Identification of a mammalian protein that binds specifically to DNA containing methylated CpGsCell, 1989
- A fraction of the mouse genome that is derived from islands of nonmethylated, CpG-rich DNACell, 1985